Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03921151 · ClinicalTrials.gov registry record · Phase 1

5HT2CR Balance in Brain Connectivity in Cocaine Dependence

A Phase 1 study, sponsored by Virginia Commonwealth University.

Completed
Registry status
Phase 1
Development phase
90
Enrollment target

NCT03921151: Completed Phase 1 study, sponsored by Virginia Commonwealth University.

NCT03921151 is a Phase 1 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 90 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03921151, a Phase 1 study, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
Phase 1
Development phase
90 participants
Enrollment target

Study Summary

This project will evaluate the role of the 5-HT2CR:5-HT2AR balance in impulsive action and cue reactivity in cocaine-dependent subjects as compared to non-drug using controls.

Primary Outcome

Change in fMRI activation during Go/NoGo (impulsivity) task with placebo dose vs Mirtazapine dose. Brain activation measured using blood-oxygen-level dependent (BOLD) contrast

Interventions

  • DRUG Mirtazapine 15 MG Oral Tablet

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2014-05-13
Est. Completion 2019-01-24
Phase Phase 1
Virginia Commonwealth University

558 total trials

What the finished NCT03921151 record still lists

NCT03921151 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% higher).

The record links to 0 conditions, and to 1 intervention - of which Mirtazapine 15 MG Oral Tablet is the first listed.

NCT03921151 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03921151 about?

NCT03921151 is a clinical study titled "5HT2CR Balance in Brain Connectivity in Cocaine Dependence". This project will evaluate the role of the 5-HT2CR:5-HT2AR balance in impulsive action and cue reactivity in cocaine-dependent subjects as compared to non-drug using controls.

What is the current status of trial NCT03921151?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 90 participants. The study started on 2014-05-13. Estimated completion is 2019-01-24.

What interventions are being tested in trial NCT03921151?

The interventions under investigation include: Mirtazapine 15 MG Oral Tablet (DRUG).

Who is sponsoring clinical trial NCT03921151?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03921151's enrollment target sits among peer trials

90 628th of 2000 higher than 1,352 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03921151, the US trial registry maintained by the National Library of Medicine. NCT03921151 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.